Rani Therapeutics
RANI
RANI
28 hedge funds and large institutions have $29.1M invested in Rani Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 0 closing their positions.
Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
9
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$1.16M |
2 |
TWA
2
TPB Wealth Advisors
San Antonio,
Texas
|
$742K |
3 |
3
BlackRock
New York
|
$2.14M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$3.44M |
5 |
CCM
5
Crossvault Capital Management
San Antonio,
Texas
|
$148K |
Top Sellers
1 |
1
Goldman Sachs
New York
|
$111K |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$12K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$26K |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$22K |
5 |
5
Osaic Holdings
Scottsdale,
Arizona
|
$196K |